Ultrasonic Ablation of Barrett's Esophagus

Information

  • Research Project
  • 6740364
  • ApplicationId
    6740364
  • Core Project Number
    R43CA105914
  • Full Project Number
    1R43CA105914-01
  • Serial Number
    105914
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/5/2004 - 20 years ago
  • Project End Date
    3/31/2005 - 19 years ago
  • Program Officer Name
    HAMILTON, FRANK A
  • Budget Start Date
    7/5/2004 - 20 years ago
  • Budget End Date
    3/31/2005 - 19 years ago
  • Fiscal Year
    2004
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/5/2004 - 20 years ago
Organizations

Ultrasonic Ablation of Barrett's Esophagus

DESCRIPTION (provided by applicant): The purpose of the proposed SBIR project is to investigate the use of High Intensity Focused Ultrasound for the treatment of esophageal tissue, with the ultimate goal of developing an ultrasound ablation system for the treatment of Barrett's Esophagus, a pre-cancerous condition that affects approximately 2 million Americans. Although current therapies for Barrett's Esophagus exist, no successful treatment, which significantly improves the patient's quality of life, is available. The proposed project will lead to a new therapeutic approach, which will be available to physicians worldwide to treat the disorder. Phase I of the project will concentrate primarily on determining whether ultrasound can be effectively focused and ablate the thin layer of esophageal tissue without damaging underlying tissues. Excised esophagus will be used to characterize tissue ultrasonically. These biophysical data will be used in computer simulations to design an appropriate ultrasound therapeutic system in Phase II. Excised esophagus from both human and porcine will be measured and compared ultrasonically so that a porcine model can be used for in vivo studies in Phase II. Differences and similarities between human and porcine tissue will be incorporated into the model. Significant societal benefits will be realized in terms of improved quality of life, rapid patient recovery, and reduced medical costs. Resulting benefits will also include increased economic activity in terms of medical device manufacturing.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    164931
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    394
  • Ed Inst. Type
  • Funding ICs
    NCI:164931\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    PIEZOTECH, LLC
  • Organization Department
  • Organization DUNS
  • Organization City
    INDIANAPOLIS
  • Organization State
    IN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    46268
  • Organization District
    UNITED STATES